The U.S. National Institutes of Health (NIH) contributed $8.1 billion in project funding for phased clinical trials involving drugs approved by the FDA from 2010-2019, according to a new study from Bentley University 's Center for Integration of Science and Industry . The study, published in JAMA Health Forum, shows that NIH funding for clinical trials represents The article , titled "Spending on phased clinical development of approved drugs by the US National Institutes of Health compared with industry" is the first to broadly assess the NIH contribution to clinical development of new drugs and compare the scale of NIH spending relative to reported spending by industry.

https://www.miragenews.com/nih-spent-8-1b-on-phased-clinical-trials-for-1047322/

#miragenews